Benzinga | May 6, 2021 08:56AM EDT

Catalyst Biosciences Q1 EPS $(0.79) Down From $(0.28) YoY, Sales $1.47M Down From $16.37M YoY

Catalyst Biosciences (NASDAQ:CBIO) reported quarterly losses of $(0.79) per share. This is a 182.14 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $1.47 million in sales this quarter. This is a 91.04 percent decrease over sales of $16.37 million the same period last year.